Candesartan (candesartan cilexetil): Reviews and patient testimonials

Candesartan 16mg Tablets

Candesartan 16mg Tablets is indicated for the:

- Treatment of essential hypertension in adults

- Treatment of hypertension in children and adolescents aged 6 to <18 years.

- The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan 32mg Tablets

Candesartan 32mg Tablets is indicated for the:

- Treatment of essential hypertension in adults

- Treatment of hypertension in children and adolescents aged 6 to <18 years.

- The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan 4mg Tablets

Candesartan 4mg Tablets is indicated for the:

- Treatment of essential hypertension in adults

- Treatment of hypertension in children and adolescents aged 6 to <18 years.

- The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan 8mg Tablets

Candesartan 8mg Tablets is indicated for the:

- Treatment of essential hypertension in adults

- Treatment of hypertension in children and adolescents aged 6 to <18 years.

- The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Route of administration: Oral
Molecule: candesartan cilexetil